PMID: 3311648Nov 1, 1987

Ketanserin, a new blocking agent of serotonin S2-receptors. Respiratory functional effects in chronic obstruction of the airways

M CazzolaD Lauria


The role played by serotonin (5-HT) in the regulation of bronchomotor tone has up to now been a much debated question, although there is good evidence that it induces intense bronchoconstriction after inhalation in asthmatic patients. Serotonin has been found to contract the tracheobronchial smooth muscle of different animals. Some data suggest that tracheobronchial contraction due to serotonin is mediated by its interaction with the S2-receptor. The blockade of this receptor by ketanserin, a serotoninergic antagonist which primarily binds to S2-serotoninergic receptors, produces bronchodilation. The respiratory effects of intravenously administered ketanserin (10 mg) or placebo were compared in a double-blind crossover study in 14 patients with chronic obstruction of the airways. The forced expiratory volume in one second (FEV1) and the instantaneous forced expiratory flow after 50 percent of the forced vital capacity has been exhaled (FEF50%) did not change after placebo, but they increased significantly after administration of ketanserin. The results suggest that in patients with chronic obstructive pulmonary disease, serotonin may play a role in the development of obstruction of the airways, even if the mechanism remains un...Continue Reading


Jun 1, 1995·Journal of Clinical Pharmacology·W H FrishmanB Shareef
Jan 1, 1988·European Journal of Clinical Pharmacology·D J StottS G Ball
Mar 1, 1997·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·L MastropasquaC Costagliola
Nov 4, 2011·Toxicological Sciences : an Official Journal of the Society of Toxicology·Way Kwok Wai LauJudith Choi Wo Mak
Jan 1, 1995·Allergy·M CazzolaF Rossi
Jun 1, 1993·The British Journal of Ophthalmology·C CostagliolaL Mastropasqua
Apr 18, 2012·Respiration; International Review of Thoracic Diseases·Brian D MooreEdward S Schelegle
Jan 1, 1989·The British Journal of Dermatology·M H RustinP M Dowd


Apr 1, 1978·Agents and Actions·N Chand, P Eyre
Nov 1, 1973·Thorax·H MoosaviD Heath
Jan 1, 1974·Respiration; International Review of Thoracic Diseases·M S IslamW T Ulmer
Apr 1, 1972·Angiology·S Rodbard, S Kira
Aug 1, 1984·Annals of Surgery·W V HuvalH B Hechtman

Related Concepts

Expiration, Function
Serotonin Measurement
Diastolic Blood Pressure
Antagonist Muscle Action
Contraction (Finding)
Smooth Muscle
Vital Capacity Test

Related Feeds


This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.